Literature DB >> 25749808

Post partial nephrectomy surveillance imaging: an evidence-based approach.

Lorenzo Marconi1, Michael A Gorin, Mohamad E Allaf.   

Abstract

To ensure the early detection of recurrent disease, all patients should undergo routine surveillance following partial nephrectomy for renal cell carcinoma. In order to optimize resource allocation and avoid unnecessary radiation exposure, the frequency and duration of surveillance should be tailored to the individual patient's risk of cancer recurrence. The evidence for surveillance after partial nephrectomy is presented reviewing the current literature on prognostic models and proposed surveillance protocols based on the timing and patterns of renal cell carcinoma recurrence. In addition, we review recent guidelines on post partial nephrectomy surveillance as well as the literature on novel imaging techniques that may aid in early disease discovery.

Entities:  

Mesh:

Year:  2015        PMID: 25749808     DOI: 10.1007/s11934-015-0489-7

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  44 in total

Review 1.  Clinical practice. Small renal mass.

Authors:  Inderbir S Gill; Monish Aron; Debra A Gervais; Michael A S Jewett
Journal:  N Engl J Med       Date:  2010-02-18       Impact factor: 91.245

2.  Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.

Authors:  John S Lam; Oleg Shvarts; John T Leppert; Allan J Pantuck; Robert A Figlin; Arie S Belldegrun
Journal:  J Urol       Date:  2005-08       Impact factor: 7.450

Review 3.  Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.

Authors:  Maxine Sun; Shahrokh F Shariat; Christopher Cheng; Vincenzo Ficarra; Masaru Murai; Stéphane Oudard; Allan J Pantuck; Richard Zigeuner; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2011-06-30       Impact factor: 20.096

Review 4.  Local treatments for metastases of renal cell carcinoma: a systematic review.

Authors:  Saeed Dabestani; Lorenzo Marconi; Fabian Hofmann; Fiona Stewart; Thomas B L Lam; Steven E Canfield; Michael Staehler; Thomas Powles; Börje Ljungberg; Axel Bex
Journal:  Lancet Oncol       Date:  2014-10-26       Impact factor: 41.316

5.  The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol.

Authors:  Alessandro Antonelli; Alberto Cozzoli; Danilo Zani; Tiziano Zanotelli; Maria Nicolai; Sergio Cosciani Cunico; Claudio Simeone
Journal:  BJU Int       Date:  2007-02       Impact factor: 5.588

6.  Role of FDG PET-CT in recurrent renal cell carcinoma.

Authors:  Rakesh Kumar; Varun Shandal; Shamim Ahmed Shamim; Sunil Jeph; Harmandeep Singh; Arun Malhotra
Journal:  Nucl Med Commun       Date:  2010-10       Impact factor: 1.690

7.  Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial.

Authors:  Chaitanya R Divgi; Robert G Uzzo; Constantine Gatsonis; Roman Bartz; Silke Treutner; Jian Qin Yu; David Chen; Jorge A Carrasquillo; Steven Larson; Paul Bevan; Paul Russo
Journal:  J Clin Oncol       Date:  2012-12-03       Impact factor: 44.544

8.  A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma.

Authors:  Igor Frank; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Bradley C Leibovich; Horst Zincke
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

9.  Diffusion of surgical innovation among patients with kidney cancer.

Authors:  David C Miller; Christopher S Saigal; Mousumi Banerjee; Jan Hanley; Mark S Litwin
Journal:  Cancer       Date:  2008-04-15       Impact factor: 6.860

Review 10.  Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma.

Authors:  Hsin-Yi Wang; Hueisch-Jy Ding; Jin-Hua Chen; Chih-Hao Chao; Yu-Yu Lu; Wan-Yu Lin; Chia-Hung Kao
Journal:  Cancer Imaging       Date:  2012-10-26       Impact factor: 3.909

View more
  2 in total

1.  Canadian Urological Association guideline for followup of patients after treatment of non-metastatic renal cell carcinoma.

Authors:  Wassim Kassouf; Leonardo L Monteiro; Darrel E Drachenberg; Adrian S Fairey; Antonio Finelli; Anil Kapoor; Jean-Baptiste Lattouf; Michael J Leveridge; Nicholas E Power; Frederic Pouliot; Ricardo A Rendon; Robert Sabbagh; Alan I So; Simon Tanguay; Rodney H Breau
Journal:  Can Urol Assoc J       Date:  2018-05-31       Impact factor: 1.862

Review 2.  Follow-up after curative treatment of localised renal cell carcinoma.

Authors:  Saeed Dabestani; Lorenzo Marconi; Teele Kuusk; Axel Bex
Journal:  World J Urol       Date:  2018-05-16       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.